{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:28:20Z","timestamp":1793968100172,"version":"4.8.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100031478","name":"NextGenerationEU","doi-asserted-by":"publisher","award":["PE00000007"],"award-info":[{"award-number":["PE00000007"]}],"id":[{"id":"10.13039\/100031478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ejmech.2026.119403","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:05:35Z","timestamp":1791389135000},"page":"119403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["Pyridobenzothiazolones as non-nucleoside antivirals: From HCV polymerase inhibition to broad-spectrum antiviral agents"],"prefix":"10.1016","volume":"321","author":[{"given":"Francesca","family":"Speranza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Massa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9753-3572","authenticated-orcid":false,"given":"Federica","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6098-3991","authenticated-orcid":false,"given":"Mario","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0207-3927","authenticated-orcid":false,"given":"Giuseppe","family":"Manfroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloise","family":"Mastrangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119403_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.amsu.2022.103985","article-title":"Comparative overview of emerging RNA viruses: epidemiology, pathogenesis, diagnosis and current treatment","volume":"79","author":"Chakrabartty","year":"2022","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.ejmech.2026.119403_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1039\/D0AY01886D","article-title":"Detection of RNA viruses from influenza and HIV to Ebola and SARS-CoV-2: a review","volume":"13","author":"Bukasov","year":"2021","journal-title":"Anal. Methods"},{"key":"10.1016\/j.ejmech.2026.119403_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2026.119403_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/1751-7915.70376","article-title":"Extending the targets for coronavirus antivirals beyond that of approved drugs: insights from preclinical research","volume":"19","author":"Br\u00fcssow","year":"2026","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.ejmech.2026.119403_bib5","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.bmc.2011.11.061","article-title":"Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase","volume":"20","author":"Manfroni","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119403_bib54","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.antiviral.2016.09.007","article-title":"Targeting flavivirus RNA dependent RNA polymerase through a pyridobenzothiazole inhibitor","volume":"134","author":"Tarantino","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119403_bib55","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01294-19","article-title":"NS5 from dengue virus serotype 2 can adopt a conformation analogous to that of its zika virus and Japanese encephalitis virus homologues","volume":"94","author":"El Sahili","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119403_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104536","article-title":"Structure of the yellow fever NS5 protein reveals conserved drug targets shared among flaviviruses","volume":"169","author":"Dubankova","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119403_bib57","doi-asserted-by":"crossref","first-page":"10678","DOI":"10.1074\/jbc.M607273200","article-title":"Crystal structure of the RNA polymerase domain of the West Nile Virus non-structural protein 5","volume":"282","author":"Malet","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119403_bib58","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/nar\/gkaa1250","article-title":"Crystal structure of a tick-borne flavivirus RNA-dependent RNA polymerase suggests a host adaptation hotspot in RNA viruses","volume":"49","author":"Yang","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.119403_bib59","doi-asserted-by":"crossref","first-page":"29765","DOI":"10.1074\/jbc.M505423200","article-title":"Interdomain communication in hepatitis C virus polymerase abolished by small molecule inhibitors bound to a novel allosteric site","volume":"280","author":"Di Marco","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119403_bib60","doi-asserted-by":"crossref","first-page":"W320","DOI":"10.1093\/nar\/gku316","article-title":"Deciphering key features in protein structures with the new ENDscript server","volume":"42","author":"Robert","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.119403_bib6","article-title":"Small molecule inhibition of Mononegavirales RNA polymerases","volume":"98","author":"Cao","year":"2026","journal-title":"Virology"},{"key":"10.1016\/j.ejmech.2026.119403_bib7","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.2174\/1381612826666200523174753","article-title":"A review on the progress and prospects of dengue drug discovery targeting NS5 RNA-dependent RNA polymerase","volume":"26","author":"Maddipati","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmech.2026.119403_bib8","series-title":"Subcellular Biochemistry","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-981-10-8456-0_3","article-title":"Viral RNA-dependent RNA polymerases: a structural overview","author":"Ferrero","year":"2018"},{"key":"10.1016\/j.ejmech.2026.119403_bib9","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2026.119403_bib10","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1007\/s00018-014-1695-z","article-title":"Common and unique features of viral RNA-dependent polymerases","volume":"71","author":"te Velthuis","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2026.119403_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3390\/v10020076","article-title":"RNA dependent RNA polymerases: insights from structure, function and evolution","volume":"10","author":"Venkataraman","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119403_bib12","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.3390\/v7082829","article-title":"RNA-dependent RNA polymerases of picornaviruses: from the structure to regulatory mechanisms","volume":"7","author":"Ferrer-Orta","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119403_bib13","doi-asserted-by":"crossref","first-page":"15642","DOI":"10.1073\/pnas.1920427117","article-title":"Closing and opening of the RNA polymerase trigger loop","volume":"117","author":"Mazumder","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2026.119403_bib14","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2318527121","article-title":"Structural basis of transcription: RNA polymerase II substrate binding and metal coordination using a free-electron laser","volume":"121","author":"Lin","year":"2024","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2026.119403_bib15","doi-asserted-by":"crossref","first-page":"10624","DOI":"10.1074\/jbc.RA120.013906","article-title":"Picornaviral polymerase domain exchanges reveal a modular basis for distinct biochemical activities of viral RNA-dependent RNA polymerases","volume":"295","author":"Watkins","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119403_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.virusres.2017.01.026","article-title":"Picornaviral polymerase structure, function, and fidelity modulation","volume":"234","author":"Peersen","year":"2017","journal-title":"Virus Res."},{"key":"10.1016\/j.ejmech.2026.119403_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104793","article-title":"Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 exonuclease active-sites","volume":"178","author":"Shannon","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119403_bib18","first-page":"57","article-title":"Nucleoside analogues for the treatment of coronavirus infections","volume":"35","author":"Pruijssers","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.ejmech.2026.119403_bib19","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.RA120.013679","article-title":"Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119403_bib20","first-page":"1499","article-title":"Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir","volume":"368","author":"Yin","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.119403_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01652-20","article-title":"Repurposing nucleoside analogs for human coronaviruses","volume":"65","author":"Zandi","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119403_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13027-020-00302-x","article-title":"Knowledge-based repositioning of the anti-HCV direct antiviral agent Sofosbuvir as SARS-CoV-2 treatment","volume":"15","author":"Buonaguro","year":"2020","journal-title":"Infect. Agents Cancer"},{"key":"10.1016\/j.ejmech.2026.119403_bib23","article-title":"Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study","volume":"253","author":"Elfiky","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2026.119403_bib24","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1093\/infdis\/jiy398","article-title":"A single nucleoside viral polymerase inhibitor against norovirus, rotavirus, and sapovirus-induced diarrhea","volume":"218","author":"Van Dycke","year":"2018","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2026.119403_bib25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1039\/D0MD00318B","article-title":"Recent advances in the discovery of potent RNA-dependent RNA-polymerase (RdRp) inhibitors targeting viruses","volume":"12","author":"Kumar","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119403_bib26","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1021\/jm050859x","article-title":"SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase","volume":"49","author":"Powers","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119403_bib27","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1021\/jm401396p","article-title":"Discovery and early development of TMC647055, a non-nucleoside inhibitor of the hepatitis C virus NS5B polymerase","volume":"57","author":"Cummings","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119403_bib28","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.febslet.2014.03.021","article-title":"PPNDS inhibits murine norovirus RNA-dependent RNA-polymerase mimicking two RNA stacking bases","volume":"588","author":"Croci","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejmech.2026.119403_bib29","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.bmcl.2013.02.110","article-title":"Discovery of a novel series of non-nucleoside thumb pocket 2 HCV NS5B polymerase inhibitors","volume":"23","author":"Stammers","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119403_bib30","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.1021\/jm040134d","article-title":"Non-nucleoside benzimidazole-based allosteric inhibitors of the hepatitis C virus NS5B polymerase: inhibition of subgenomic hepatitis C virus RNA replicons in Huh-7 cells","volume":"47","author":"Beaulieu","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119403_bib31","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1021\/jm201384j","article-title":"Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase","volume":"55","author":"Sofia","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119403_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3390\/v18030279","article-title":"The RNA-binding domain NS1 of influenza as an antiviral target: from evolutionary conservation mapping to experimental validation","volume":"18","author":"Santos","year":"2026","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119403_bib33","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2026.2620222","article-title":"Emergence of the novel PA-D27G mutation conferring reduced baloxavir susceptibility in influenza A viruses circulating in China, 2018\u20132025","volume":"15","author":"Sun","year":"2026","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.ejmech.2026.119403_bib34","doi-asserted-by":"crossref","first-page":"7650","DOI":"10.1021\/jm3006788","article-title":"Discovery of the first thumb pocket 1 NS5B polymerase inhibitor (BILB 1941) with demonstrated antiviral activity in patients chronically infected with genotype 1 hepatitis C virus (HCV)","volume":"55","author":"Beaulieu","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119403_bib35","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1128\/AAC.02052-12","article-title":"Preclinical characterization of GS-9669, a thumb site II inhibitor of the hepatitis C virus NS5B polymerase","volume":"57","author":"Fenaux","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2026.119403_bib36","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1128\/AAC.02495-13","article-title":"Preclinical characterization of BMS-791325, an allosteric inhibitor of hepatitis C virus NS5B polymerase, antimicrob","volume":"58","author":"Lemm","year":"2014","journal-title":"Agents Chemother"},{"key":"10.1016\/j.ejmech.2026.119403_bib37","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.antiviral.2012.04.008","article-title":"Discovery of substituted N-phenylbenzenesulphonamides as a novel class of non-nucleoside hepatitis C virus polymerase inhibitors","volume":"95","author":"May","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119403_bib38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1139\/bcb-2015-0109","article-title":"Molecular modeling study on the drug resistance mechanism of NS5B polymerase to TMC647055","volume":"94","author":"Wang","year":"2016","journal-title":"Biochem. Cell. Biol."},{"key":"10.1016\/j.ejmech.2026.119403_bib39","article-title":"Identification of NS5B resistance-associated mutations in hepatitis C virus circulating in treatment-na\u00efve Cameroonian patients","volume":"18","author":"Mounchili-Njifon","year":"2026","journal-title":"IJID Reg"},{"key":"10.1016\/j.ejmech.2026.119403_bib40","article-title":"Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals","volume":"4","author":"Howe","year":"2022","journal-title":"JHEP Rep."},{"key":"10.1016\/j.ejmech.2026.119403_bib41","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/jvh.12536","article-title":"Antiviral response and resistance analysis of treatment-na\u00efve HCV-infected patients receiving single and multiple doses of GS-9190","volume":"23","author":"Mo","year":"2016","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.ejmech.2026.119403_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01130-20","article-title":"Two RNA tunnel inhibitors bind in highly conserved sites in dengue virus NS5 polymerase: structural and functional studies","volume":"94","author":"Arora","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2026.119403_bib43","doi-asserted-by":"crossref","first-page":"18356","DOI":"10.1021\/acs.jmedchem.5c01014","article-title":"Crystallographic fragment screening of the dengue virus polymerase reveals multiple binding sites for the development of non-nucleoside antiflavivirals","volume":"68","author":"Saini","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119403_bib44","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.chom.2023.06.013","article-title":"Acetylation of the NS3 helicase by KAT5\u03b3 is essential for flavivirus replication","volume":"31","author":"Serman","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ejmech.2026.119403_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41580-021-00432-z","article-title":"Structures and functions of coronavirus replication\u2013transcription complexes and their relevance for SARS-CoV-2 drug design","volume":"23","author":"Malone","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119403_bib46","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3390\/cells15100930","article-title":"Split reporter systems in viral protein\u2013protein interactions and multimerization: mechanisms and applications","volume":"15","author":"Ahmad","year":"2026","journal-title":"Cells"},{"key":"10.1016\/j.ejmech.2026.119403_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.109346","article-title":"Therapeutic potential of protein\u2013protein interaction modulators in antiviral research","volume":"168","author":"Kaur","year":"2026","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119403_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104531","article-title":"Targeting viral replication complexes with mRNA-encoded nanobodies: a new frontier for antiviral design","volume":"30","author":"Blavier","year":"2025","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2026.119403_bib49","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3390\/v14061157","article-title":"Virucidal activity of the pyridobenzothiazolone derivative HeE1-17Y against enveloped RNA viruses","volume":"14","author":"Milan","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119403_bib50","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2419854122","article-title":"Structural basis of SARS-CoV-2 polymerase inhibition by nonnucleoside inhibitor HeE1-2Tyr","volume":"122","author":"Kabinger","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2026.119403_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2026.117462","article-title":"Structural mechanism of Borna disease virus 1 RNA polymerase autoinhibition and suramin-mediated inhibition","volume":"45","author":"Yang","year":"2026","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2026.119403_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500163","article-title":"New pyridobenothiazolone derivatives display nanomolar pan-serotype anti-dengue virus activity","volume":"20","author":"Felicetti","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.119403_bib64","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.antiviral.2019.03.004","article-title":"Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions","volume":"167","author":"Cannalire","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2026.119403_bib61","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1021\/acsmedchemlett.9b00619","article-title":"Pyridobenzothiazolones exert potent anti-dengue activity by hampering multiple functions of NS5 polymerase","volume":"11","author":"Cannalire","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119403_bib62","article-title":"Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents","volume":"210","author":"Felicetti","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119403_bib65","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3390\/v17070890","article-title":"Broad-spectrum antiviral activity of pyridobenzothiazolone analogues against respiratory viruses","volume":"17","author":"Feyles","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119403_bib53","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1248\/cpb.27.1186","article-title":"Studies on ketene and its derivatives. XCVI. Synthesis of pyrido[2,1-b]benzoazoles","volume":"27","author":"Kato","year":"1979","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejmech.2026.119403_bib63","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.3390\/molecules28145495","article-title":"Approach to Pyrido[2,1-b][1,3]benzothiazol-1-ones via in situ generation of Acyl(1,3-benzothiazol-2-yl)ketenes by thermolysis of Pyrrolo[2,1-c][1,4]benzothiazine-1,2,4-triones","volume":"28","author":"Lystsova","year":"2023","journal-title":"Molecules"},{"issue":"15","key":"10.1016\/j.ejmech.2026.119403_bib66","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1016\/j.molcel.2023.06.023","article-title":"Structures of dengue virus RNA replicase complexes","volume":"83","author":"Osawa","year":"2023","journal-title":"Mol Cell"},{"key":"10.1016\/j.ejmech.2026.119403_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008156","article-title":"Comprehensive response to Usutu virus following first isolation in blood donors in the Friuli Venezia Giulia region of Italy: development of recombinant NS1-based serology and sensitivity to antiviral drugs","volume":"14","author":"Caracciolo","year":"2020","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ejmech.2026.119403_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116180","article-title":"Recent advancements in the discovery of small-molecule non-nucleoside inhibitors targeting SARS-CoV-2 RdRp","volume":"171","author":"Zhou","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.119403_bib69","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3762\/bjoc.20.91","article-title":"Novel analogues of a nonnucleoside SARS-CoV-2 RdRp inhibitor as potential antivirotics","volume":"20","author":"T\u00f3th","year":"2024","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.119403_bib70","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3390\/v13081585","article-title":"Non-nucleotide RNA-dependent RNA polymerase inhibitor that blocks SARS-CoV-2 replication","volume":"13","author":"Dejmek","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ejmech.2026.119403_bib71","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12268-026-2690-2","article-title":"Coronavirus-Replikation: inhibition durch HeE1-2Tyr","volume":"32","author":"Dienemann","year":"2026","journal-title":"Biospektrum"},{"key":"10.1016\/j.ejmech.2026.119403_bib72","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nrd2445","article-title":"The influence of drug-like concepts on decision-making in medicinal chemistry","volume":"6","author":"Leeson","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119403_bib73","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1021\/acsmedchemlett.8b00177","article-title":"Identification of N-Benzyl 3,5-Dinitrobenzamides derived from PBTZ169 as antitubercular agents","volume":"9","author":"Li","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119403_bib74","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jconrel.2017.08.033","article-title":"Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases","volume":"264","author":"Tapeinos","year":"2017","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2026.119403_bib75","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/molecules23010047","article-title":"Mesoporous silica nanoparticles for drug delivery: current insights","volume":"23","author":"Vallet-Reg\u00ed","year":"2017","journal-title":"Molecules"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426008482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T11:57:40Z","timestamp":1793966260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426008482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":75,"alternative-id":["S0223523426008482"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119403","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyridobenzothiazolones as non-nucleoside antivirals: From HCV polymerase inhibition to broad-spectrum antiviral agents","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119403","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119403"}}